Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery

George Melnik, Wayne H Schwesinger, Lisa C. Dogolo, Renli Teng, John Vincent

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

BACKGROUND: Trovafloxacin is a new fourth-generation fluoroquinolone whose pharmacokinetics and in vitro activity suggest that it is well suited for antibiotic prophylaxis in elective colorectal surgery. Alatrofloxacin is a prodrug that is rapidly hydrolyzed to trovafloxacin in the body. METHODS: Twelve patients received a single dose of alatrofloxacin equivalent to 200 mg trovafloxacin by intravenous infusion over 1 hour. Surgery was started at various time points relative to infusion time to allow determination of trovafloxacin concentrations in serum, colonic tissue, and peritoneal fluid as a function of time. RESULTS: The concentration in the earliest colonic tissue sample (1.4 hours after dosing) was 1.4 μg/g. The maximum colonic tissue concentration was 2.8 μg/g in a sample taken 2 hours after dosing. Colonic tissue/serum concentration ratios in samples taken 2-10 hours after the end of infusion ranged from 0.8 to 1.47. Concentrations of trovafloxacin in peritoneal fluid ranged from below the level of quantitation to 2.1 μg/mL at the time of colonic tissue sampling and from below the level of quantitation to 2.5 μg/mL at the time of wound closure. Alatrofloxacin was well tolerated. CONCLUSIONS: After a single intravenous dose of alatrofloxacin equivalent to 200 mg trovafloxacin, trovafloxacin is distributed rapidly into colonic tissue and peritoneal fluids. Tissue concentrations approximate serum concentrations and decline in parallel for up to 10 hours after dosing.

Original languageEnglish (US)
JournalAmerican Journal of Surgery
Volume176
Issue number6 A
DOIs
StatePublished - Dec 1998

Fingerprint

Colorectal Surgery
Ascitic Fluid
Prodrugs
Intravenous Infusions
Serum
Antibiotic Prophylaxis
Fluoroquinolones
alatrofloxacin
trovafloxacin
Pharmacokinetics
Wounds and Injuries

ASJC Scopus subject areas

  • Surgery

Cite this

Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery. / Melnik, George; Schwesinger, Wayne H; Dogolo, Lisa C.; Teng, Renli; Vincent, John.

In: American Journal of Surgery, Vol. 176, No. 6 A, 12.1998.

Research output: Contribution to journalArticle

@article{b75afaec84174e569ba24b88c4f0358d,
title = "Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery",
abstract = "BACKGROUND: Trovafloxacin is a new fourth-generation fluoroquinolone whose pharmacokinetics and in vitro activity suggest that it is well suited for antibiotic prophylaxis in elective colorectal surgery. Alatrofloxacin is a prodrug that is rapidly hydrolyzed to trovafloxacin in the body. METHODS: Twelve patients received a single dose of alatrofloxacin equivalent to 200 mg trovafloxacin by intravenous infusion over 1 hour. Surgery was started at various time points relative to infusion time to allow determination of trovafloxacin concentrations in serum, colonic tissue, and peritoneal fluid as a function of time. RESULTS: The concentration in the earliest colonic tissue sample (1.4 hours after dosing) was 1.4 μg/g. The maximum colonic tissue concentration was 2.8 μg/g in a sample taken 2 hours after dosing. Colonic tissue/serum concentration ratios in samples taken 2-10 hours after the end of infusion ranged from 0.8 to 1.47. Concentrations of trovafloxacin in peritoneal fluid ranged from below the level of quantitation to 2.1 μg/mL at the time of colonic tissue sampling and from below the level of quantitation to 2.5 μg/mL at the time of wound closure. Alatrofloxacin was well tolerated. CONCLUSIONS: After a single intravenous dose of alatrofloxacin equivalent to 200 mg trovafloxacin, trovafloxacin is distributed rapidly into colonic tissue and peritoneal fluids. Tissue concentrations approximate serum concentrations and decline in parallel for up to 10 hours after dosing.",
author = "George Melnik and Schwesinger, {Wayne H} and Dogolo, {Lisa C.} and Renli Teng and John Vincent",
year = "1998",
month = "12",
doi = "10.1016/S0002-9610(98)00214-1",
language = "English (US)",
volume = "176",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "6 A",

}

TY - JOUR

T1 - Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery

AU - Melnik, George

AU - Schwesinger, Wayne H

AU - Dogolo, Lisa C.

AU - Teng, Renli

AU - Vincent, John

PY - 1998/12

Y1 - 1998/12

N2 - BACKGROUND: Trovafloxacin is a new fourth-generation fluoroquinolone whose pharmacokinetics and in vitro activity suggest that it is well suited for antibiotic prophylaxis in elective colorectal surgery. Alatrofloxacin is a prodrug that is rapidly hydrolyzed to trovafloxacin in the body. METHODS: Twelve patients received a single dose of alatrofloxacin equivalent to 200 mg trovafloxacin by intravenous infusion over 1 hour. Surgery was started at various time points relative to infusion time to allow determination of trovafloxacin concentrations in serum, colonic tissue, and peritoneal fluid as a function of time. RESULTS: The concentration in the earliest colonic tissue sample (1.4 hours after dosing) was 1.4 μg/g. The maximum colonic tissue concentration was 2.8 μg/g in a sample taken 2 hours after dosing. Colonic tissue/serum concentration ratios in samples taken 2-10 hours after the end of infusion ranged from 0.8 to 1.47. Concentrations of trovafloxacin in peritoneal fluid ranged from below the level of quantitation to 2.1 μg/mL at the time of colonic tissue sampling and from below the level of quantitation to 2.5 μg/mL at the time of wound closure. Alatrofloxacin was well tolerated. CONCLUSIONS: After a single intravenous dose of alatrofloxacin equivalent to 200 mg trovafloxacin, trovafloxacin is distributed rapidly into colonic tissue and peritoneal fluids. Tissue concentrations approximate serum concentrations and decline in parallel for up to 10 hours after dosing.

AB - BACKGROUND: Trovafloxacin is a new fourth-generation fluoroquinolone whose pharmacokinetics and in vitro activity suggest that it is well suited for antibiotic prophylaxis in elective colorectal surgery. Alatrofloxacin is a prodrug that is rapidly hydrolyzed to trovafloxacin in the body. METHODS: Twelve patients received a single dose of alatrofloxacin equivalent to 200 mg trovafloxacin by intravenous infusion over 1 hour. Surgery was started at various time points relative to infusion time to allow determination of trovafloxacin concentrations in serum, colonic tissue, and peritoneal fluid as a function of time. RESULTS: The concentration in the earliest colonic tissue sample (1.4 hours after dosing) was 1.4 μg/g. The maximum colonic tissue concentration was 2.8 μg/g in a sample taken 2 hours after dosing. Colonic tissue/serum concentration ratios in samples taken 2-10 hours after the end of infusion ranged from 0.8 to 1.47. Concentrations of trovafloxacin in peritoneal fluid ranged from below the level of quantitation to 2.1 μg/mL at the time of colonic tissue sampling and from below the level of quantitation to 2.5 μg/mL at the time of wound closure. Alatrofloxacin was well tolerated. CONCLUSIONS: After a single intravenous dose of alatrofloxacin equivalent to 200 mg trovafloxacin, trovafloxacin is distributed rapidly into colonic tissue and peritoneal fluids. Tissue concentrations approximate serum concentrations and decline in parallel for up to 10 hours after dosing.

UR - http://www.scopus.com/inward/record.url?scp=0032466996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032466996&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(98)00214-1

DO - 10.1016/S0002-9610(98)00214-1

M3 - Article

C2 - 9935251

AN - SCOPUS:0032466996

VL - 176

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 6 A

ER -